Meeting to be held in Montreal on October 3 and in Chicago on October 4 hosted by Craig-Hallum.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on LGND:
- Ligand: FDA decision on berdazimer gel NDA expected in January of 2024
- Ligand to acquire assets of Novan, following July 17 offer
- Ligand CEO buys $237.5K in common stock
- Ligand’s partner Jazz Pharmaceuticals receives EC approval for Enrylaze
- Ligand raises FY23 EPS to $5.10-$5.25 from $4.85-$5.00, consensus $4.98